Elon Musk’s company Neuralink said on May 25, 2023 that it received permission from the US Food and Drug Administration to begin clinical research involving the placement of brain implants on humans, Reuters reported.
At least four times since 2019, Musk has predicted that his company will soon begin human trials of brain implants
At least four times since 2019, Musk has predicted that his company will soon begin human trials of brain implants to communicate with computers directly by thought. They are initially intended to help people who are paralysed or suffering from neurological diseases as blindness. The start-up then wants to make these implants safe and reliable enough to be used for elective surgery. People could then pay a few thousand dollars to equip their brains with computer power.
The Californian company stated that “recruitment for clinical trials is not yet open”.
However, the company, founded in 2016, requested permission to conduct such tests for the first time only at the beginning of last year. But then the Food and Drug Administration refused to grant permission, sources familiar with the matter told Reuters in March.
The US Food and Drug Administration has not yet responded to a Reuters request for comment on the Neuralink approval.
